(1 - 30 von 43
)
Google News - Peter Langecker - Aktuell
news.google.com
Mit Google News kannst du zum Thema Peter Langecker vollständige Artikel lesen, Videos ansehen und in Tausenden von Titeln stöbern.
Oxigene Inc says drug meets main goal of ovarian cancer trial |...
www.reuters.com
Oxigene Inc said on Tuesday that its experimental drug Zybrestat combined with Roche's big selling cancer drug Avastin significantly slowed progression of...
Peter Langecker - Latest News and breaking headlinesBenzinga
www.benzinga.com
Peter Langecker. Top Trending Tickers On StockTwits For March 12. Peter Langecker Recent News. Popular Channels. PreMarket Prep · Press Releases ...
Oxigene Inc says drug meets main goal of ovarian cancer ...Reuters
www.reuters.com
— ... are evaluating next steps to advance this combination to patients in need,” Oxigene Chief Executive Peter Langecker said in a statement.
BRIEF-Oxigene says CEO resigns, names interim CEO
www.finanznachrichten.de
... Inc: * Announces management changes * Says CEO John Kollins resigned * Says Peter Langecker will serve as interim chief executive officer ((Bangalore ...
DURECT Appoints Joseph Stauffer As CMO And EVP, Corporate Strategy -...
www.nsmedicaldevices.com
DURECT Appoints Joseph Stauffer As CMO And EVP, Corporate Strategy. MDBR Staff Writer Published 16 June I should also note that Dr. Peter Langecker, ...
Latest news about Peter Langecker - Stock Market | Marketsfinance.dalycity.com › category
finance.dalycity.com
Daly City, CA September 01, :20pm 7-Day Forecast | Traffic · Home · News · Daly City News · Local News · Bay Area News · Business · Technology · Real ...
OXiGENE Reports Fourth Quarter and Year-End Results - dgap.de
www.eqs-news.com
OXiGENE Reports Fourth Quarter and Year-End Results | Oxigene, Inc. | News | Nachricht | Mitteilung
OXiGENE Appoints Tamar D. Howson and Peter J. Langecker to Its Board...
www.eqs-news.com
OXiGENE Appoints Tamar D. Howson and Peter J. Langecker to Its Board of Directors | Oxigene, Inc. | News | Nachricht | Mitteilung
OXiGENE Announces Results of Promising Preclinical Studies at
www.benzinga.com
... anti-cancer therapies, which we believe represent important assets for our company," said Peter Langecker, M.D., Ph.D., Chief Executive Officer at OXiGENE.
OXiGENE shares plummet on restructuring plan, halts trials, cuts...
www.proactiveinvestors.co.uk
... financial resources, but, in light of the challenges in funding such a rare orphan disease, that is not possible at the present time," said CEO Peter Langecker.
Experimental ovarian cancer drug meets main goal in trial ...www.careacross.com › news › exp...
www.careacross.com
... we are evaluating next steps to advance this combination to patients in need," Oxigene Chief Executive Peter Langecker said in a statement.
OXiGENE completes enrolment in phase-2 study of ...Pharmabiz.com
test.pharmabiz.com
... combinability with other treatment modalities, including anti-angiogenic agents," said Peter Langecker, M.D., chief executive officer at OXiGENE.
Oxigene Announces Management Changes | CorporateEQS News
www.eqs-news.com
Dr. Peter Langecker, M.D., Ph.D., Executive Vice President and Chief Development Officer, will serve as Interim Chief Executive Officer while the Company ...
Top Trending Tickers On StockTwits For March Benzinga
www.benzinga.com
OXiGENE's CEO Peter Langecker confirmed that the company is evaluating the next step to bring the drug to patients in need given that the ...
OXiGENE Reports First Quarter Financial Results - dgap.de
www.eqs-news.com
OXiGENE Reports First Quarter Financial Results | Oxigene, Inc. | News | Nachricht | Mitteilung
OXiGENE Applies for Voluntary Delisting From the Stockholm Exchange -...
www.eqs-news.com
OXiGENE Applies for Voluntary Delisting From the Stockholm Exchange | Oxigene, Inc. | News | Nachricht | Mitteilung
We have good news about snacking!Constant Contact
myemail.constantcontact.com
Dr. Peter Langecker, MD, PhD is currently Executive Medical Director, Global Oncology at Clinipace. He brings to the Board over 25 years of hands-on ...
OXiGENE Receives Meeting Minutes from FDA Type C Meeting on...
www.nbcnews.com
... and constructive feedback we received from the FDA representatives," said Peter Langecker, Chief Executive Officer of OXiGENE.
OXiGENE Appoints President And CEO - Contract Pharma
www.contractpharma.com
Chaplin brings extensive R&D experience in the field oncology
OXiGENE Announces Positive Topline Results From Randomized
www.globenewswire.com
... resources and commitment of GOG and CTEP to conduct this important program," said Peter Langecker, M.D., Ph.D., chief executive officer of ...
OXiGENE Reports Encouraging Safety and Efficacy Data from Ongoing...
www.globenewswire.com
... can yield clinical benefit without increased toxicity when added to existing mainstay cancer therapies," commented Peter Langecker, M.D., ...
Biomedicines presents promising results from | EurekAlert!
www.eurekalert.org
· ... Dr. Peter Langecker, "Results from these two independent studies provide evidence for an antiviral effect against all HCV genotypes (1, 2, 3, ...
OXiGENE Reports Full Year Financial Results Other OTC:MATN
www.globenewswire.com
Commented Peter Langecker, M.D., Ph.D., OXiGENE's Chief Executive Officer: " During the past year, we have made significant progress in ...
Oxigene Licenses Angiogene IP to Support Carcinoid Syndrome Studies
www.genengnews.com
Company will initiate Phase II studies of Zybrestat, a vascular disrupting agent.
Oxigene Announces Management Changes - dgap.de
www.eqs-news.com
Oxigene Announces Management Changes | Oxigene, Inc. | News | Nachricht | Mitteilung
OXiGENE Inc : OXiGENE Reports Third Quarter Financial ...www.marketscreener.com › ... › News
www.marketscreener.com
· Commented Peter Langecker, M.D., Ph.D., OXiGENE's Chief Executive Officer: " During the third quarter, we focused on pursuing our lead ...
OXiGENE Names Experienced Biotech Executive, David J.
www.globenewswire.com
· ... that David (Dai) Chaplin, Ph.D., has been appointed to the position of President and Chief Executive Officer, replacing Peter Langecker, M.D., ...
OXiGENE Reports Full Year Financial Results - NBC Newswww.nbcnews.com › wbna
www.nbcnews.com
· ... manner," said Peter Langecker, M.D., Ph.D., OXiGENE's Chief Executive Officer. "Over the past several months we have undertaken practical, ...
sortiert nach Relevanz / Datum